La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Mesh.i » - entrée « Neurotoxins »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neurotoxicity Syndromes < Neurotoxins < Neurotransmitter Agents  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000072 (1999) C. Fillebeen [France] ; V. Mitchell ; D. Dexter ; M. Benaissa ; J. Beauvillain ; G. Spik ; A. PierceLactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment.
000118 (2000) I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. TisonToward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
000384 (2003) A. Lannuzel [France] ; P P Michel ; G U Höglinger ; P. Champy ; A. Jousset ; F. Medja ; A. Lombès ; F. Darios ; C. Gleye ; A. Laurens ; R. Hocquemiller ; E C Hirsch ; M. RubergThe mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.
000547 (2005) Wassilios Meissner [France] ; Arthur Leblois ; David Hansel ; Bernard Bioulac ; Christian E. Gross ; Abdelhamid Benazzouz ; Thomas BoraudSubthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations.
000633 (2006) Dominique Caparros-Lefebvre [France] ; John Steele ; Yaichiro Kotake ; Shigeru OhtaGeographic isolates of atypical Parkinsonism and tauopathy in the tropics: possible synergy of neurotoxins.
000652 (2006) E C Hirsch [France]How to judge animal models of Parkinson's disease in terms of neuroprotection.
000697 (2007) Dominique Langui [France] ; François Lachapelle ; Charles Duyckaerts[Animal models of neurodegenerative diseases].
000719 (2007) Laïla Amazzal [France] ; Agnès Lapôtre ; Frédéric Quignon ; Denyse BagrelMangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells.
000752 (2007) Alexis Elbaz [France] ; Christine TranchantEpidemiologic studies of environmental exposures in Parkinson's disease.
000895 (2008) Daniel Alvarez-Fischer [France] ; Serge Guerreiro ; Stéphane Hunot ; Françoise Saurini ; Marc Marien ; Pierre Sokoloff ; Etienne C. Hirsch ; Andreas Hartmann ; Patrick P. MichelModelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid.
000D73 (2011) Julien Vezoli [France, Allemagne] ; Karim Fifel [France] ; Vincent Leviel [France] ; Colette Dehay [France] ; Henry Kennedy [France] ; Howard M. Cooper [France] ; Claude Gronfier [France] ; Emmanuel Procyk [France]Early Presymptomatic and Long-Term Changes of Rest Activity Cycles and Cognitive Behavior in a MPTP-Monkey Model of Parkinson's Disease
000E01 (2010) Léon Tremblay [France][Pathophysiology of Parkinson's disease: an update].
000F27 (2012) Erwan Bezard [France] ; Zhenyu Yue [États-Unis] ; Deniz Kirik [Suède] ; Maria Grazia Spillantini [Royaume-Uni]Animal Models of Parkinson’s Disease: limits and relevance to neuroprotection studies
001164 (2013) Daniel Alvarez-Fischer [Allemagne] ; Carmen Noelker ; Anne Grünewald ; Franca Vulinovi ; Serge Guerreiro ; Julia Fuchs ; Lixia Lu ; Anne Lombès ; Etienne C. Hirsch ; Wolfgang H. Oertel ; Patrick P. Michel ; Andreas HartmannProbenecid potentiates MPTP/MPP+ toxicity by interference with cellular energy metabolism.
001843 (2016) Fannie Darlot [France] ; Cécile Moro [France] ; Nabil El Massri [Australie] ; Claude Chabrol [France] ; Daniel M. Johnstone [Australie] ; Florian Reinhart [France] ; Diane Agay [France] ; Napoleon Torres [France] ; Dhaïf Bekha [France] ; Vincent Auboiroux [France] ; Thomas Costecalde [France] ; Cassandra L. Peoples [Australie] ; Helena D T. Anastascio [Australie] ; Victoria E. Shaw [Australie] ; Jonathan Stone [Australie] ; John Mitrofanis [Australie] ; Alim-Louis Benabid [France]Near-infrared light is neuroprotective in a monkey model of Parkinson disease.
001947 (2016) Loubna Boukhzar ; Abdallah Hamieh ; Dorthe Cartier ; Yannick Tanguy ; Ifat Alsharif ; Matthieu Castex ; Arnaud Arabo ; Sana El Hajji ; Jean-Jacques Bonnet ; Mohammed Errami ; Anthony Falluel-Morel ; Abdeslam Chagraoui ; Isabelle Lihrmann ; Youssef AnouarSelenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease
001E74 (1997) S. Palfi [France] ; D. Riche ; E. Brouillet ; M C Guyot ; V. Mary ; F. Wahl ; M. Peschanski ; J M Stutzmann ; P. HantrayeRiluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.
001F01 (1997) F. Tison [France]Other causes of parkinsonism.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i -k "Neurotoxins" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/Mesh.i  \
                -Sk "Neurotoxins" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Neurotoxins
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024